2013-12-24 22:02:08 - Fast Market Research recommends "Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics" from Current Partnering, now available
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access tthe co-promotion and co-marketing partnering agreements entered intby the worlds leading healthcare companies.
Revised and updated 9th edition, includes:
* Trends in co-promotion and co-marketing deals
* Co-promotion and co-marketing agreement structure
* Co-promotion and co-marketing contract documents
* Top co-promotion deals by value
* Top co-marketing deals by value
* Most active co-promotion dealmakers
* Most active co-marketing dealmakers
Full Report Details at
- www.fastmr.com/prod/756327_copromotion_and_comarketing_partnerin ..
This report provides details of the latest co-promotion and co-marketing agreements announced in
the pharmaceutical, biotechnology and diagnostic sectors.
Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2007 tend of Sep 2013.
The report provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option tco-promote/market the resultant product of the research collaboration. There are alsnumerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order tmaximize a products presence in the marketplace.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight intthe negotiation process in terms of what you can expect tachieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases dnot.
This report contains over 850 links tonline copies of actual co-promotion and co-marketing contract documents as submitted tthe Securities Exchange Commission by biopharma companies and their partners.
Contract documents provide the answers tnumerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability tderive value from the deal.
The initial chapters of this report provide an orientation of co-promotion and co-marketing dealmaking and business activities. Chapter 1 provides an introduction tthe report, whilst chapter 2 provides an analysis of the trends in co-promotion and co-marketing as well as a discussion on the merits of each type of deal.
Chapters 3 and 4 provide an overview of the structure of co-promotion and co-marketing deals, respectively. Each chapter includes numerous case studies tenable understanding of both pure co-promotion/marketing deals and multicomponent deals where co-promotion/marketing forms a part.
Chapters 5 and 6 provide a review of the leading co-promotion and co-marketing deals since 2007, respectively. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access tthe contract via the Current Agreements deals and alliances database.
Chapter 7 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of co-promotion and co-marketing contract deals available in the public domain. Where available, each deal title links via Current Agreements deals and alliances database tan online version of the actual contract document, providing easy access teach contract document on demand.
Chapters 8 and 9 provide a comprehensive and detailed review of co-promotion and co-marketing deals signed and announced since 2007. Each chapter is organized by A-Z, stage of development at signing, and therapeutic area. Each deal title links via Weblink tan online version of the actual contract document, providing easy access teach contract document on demand.
The report alsincludes numerous table and figures that illustrate the trends and activities in co-promotion and co-marketing dealmaking since 2007.
In conclusion, this report provides everything a prospective dealmaker needs tknow about co-promotion and co-marketing as an opportunity tparticipate in the commercialization of either candidate compounds in development or products already on the market.
In addition, a comprehensive appendix is provided organized by cpromotion and cmarketing partnering company A-Z , stage of development, therapeutic target, technology type and deal type definitions. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs tknow about partnering in the research, development and commercialization of antibody technologies and products.
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics provides the reader with the following key benefits:
* In-depth understanding of co-promotion and co-marketing deal trends since 2007
* Analysis of the structure of co-promotion and co-marketing agreements with numerous real life case studies
* Comprehensive access tover 750 actual co-promotion and co-marketing deals entered intby the world's biopharma companies
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.